Use of New T-Cell-Based Cell Lines Expressing Two Luciferase Reporters for Accurately Evaluating Susceptibility to Anti-Human Immunodeficiency Virus Type 1 Drugs
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.